Cheng‐Kuo Chen

Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies.

Wei‐Fan Hsu, Hung‐Wei Wang, Cheng‐Kuo Chen et al. · PubMed · 2021 · 19 citations · Full text

Immunology, Pathology, Locoregional Therapies +18

Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience.

Wei‐Fan Hsu, Po‐Heng Chuang, Cheng‐Kuo Chen et al. · PubMed · 2020 · 18 citations · Full text

Real-world Experience, Cancer Management, Pathology +21

Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings

Cheng‐Pin Chen, Chien‐Yu Cheng, Huachun Zou et al. · Journal of Microbiology Immunology and Infection · 2018 · 17 citations · Full text

Increased risk of chronic obstructive pulmonary disease among patients with <i>Helicobacter pylori</i> infection: a population‐based cohort study

Yi‐Hao Peng, Cheng‐Kuo Chen, Ching‐Hua Su et al. · The Clinical Respiratory Journal · 2015 · 11 citations